Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • WFC vs GSK✓SelectedUSD · GSKWFC vs GSK performance historyLatest closeAs of-1.41%11/16
Stock and ETF performance explorer

WFC vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+115.7%
GSK return
+107.3%
Excess return
+8.4%
Maximum drawdown
-64.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.4%-0.1%-1.3%-1.4%
7D-0.8%-1.3%+0.6%-0.3%
30D+1.8%+2.7%-1.0%+0.7%
3M-3.9%+2.7%-6.6%-5.1%
6M+16.9%+3.3%+13.6%+14.9%
YTD-6.9%+6.5%-13.4%-10.0%
1Y+2.0%+10.7%-8.7%-2.7%
3Y+113.9%+64.4%+49.6%+66.4%
5Y+90.6%+46.7%+43.9%+54.2%
10Y+115.7%+109.4%+6.3%+51.5%
All+115.7%+107.3%+8.4%+51.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling